By Jonathan Stempel NEW YORK, Feb 23 (Reuters) - Bayer sued Johnson & Johnson on Monday, accusing the drugmaker of falsely ...
Bayer sued Johnson and Johnson, alleging false advertising for its prostate cancer drug Erleada, claiming it misleads patients.
Pharmaceutical manufacturer Johnson & Johnson is expanding its operations in Pennsylvania by building a new cell therapy ...
Feb 19 (Reuters) - Johnson & Johnson is preparing a potential sale of the orthopedics unit that it has been planning ...
A Baltimore jury ordered Johnson & Johnson and its subsidiaries to pay over $1.5 billion to a woman who claimed decades of exposure to asbestos in the company’s talc-based products caused her ...
Johnson & Johnson's stock hits a 52-week high, but key drug patent risks and a lower Wall Street price target suggest downside. Learn more about JNJ stock here.
Johnson & Johnson announced a $1 billion investment in a Montgomery County, Pennsylvania, cell therapy facility that will yield over 500 manufacturing jobs plus 4,000 construction jobs.
Minnesota jury says Johnson & Johnson owes $65.5 million to woman with cancer who used talcum powder
A Minnesota jury awarded $65.5 million on Friday to a mother of three who claimed talcum products made by Johnson & Johnson exposed her to asbestos and contributed to her developing cancer in the ...
It's about striking that perfect balance between chasing growth and protecting what you already have.
Johnson & Johnson is taking flight with the New York Jets, joining the NFL team’s roster in a multiyear agreement as its official medical innovation sponsor. Under the new sponsorship, unveiled ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results